Diabetes Publish Ahead of Print published online ahead of print August 26, 2008 DOI: 10.2337/db07-1187
Ablation of AMP-activated Protein Kinase 2 Activity Exacerbates Insulin Resistance Induced by High-fat Feeding of Mice
Nobuharu Fujii, PhD1,
Richard C. Ho, PhD1,
Yasuko Manabe, PhD1,
Niels Jessen, M.D1,
Taro Toyoda, PhD1,
William L. Holland, PhD2,
Scott A. Summers, PhD2,
Michael F. Hirshman, B.S1, and
Laurie J. Goodyear, PhD1
1Research Division, Joslin Diabetes Center and Department Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
2Division of Endocrinology, Diabetes, and Metabolism, University of Utah School of Medicine, Salt Lake City, UT
Objective: We determined if muscle AMP-activated protein kinase (AMPK) has a role in the development of insulin resistance.
Research Design And Methods: Muscle-specific transgenic mice expressing an inactive form of the AMPK 2 catalytic subunit ( 2i TG) and their wild type littermates were fed either a high-fat (60% kcal fat) or a control diet (10% kcal fat) for 30 weeks.
Results: Compared with wild type mice, glucose tolerance in 2i TG mice was slightly impaired on the control diet, and significantly impaired on the high-fat diet. To determine whether the whole body glucose intolerance was associated with impaired insulin sensitivity in skeletal muscle, glucose transport in response to submaximal insulin (450 µU/ml) was measured in isolated soleus muscles. On the control diet, insulin-stimulated glucose transport was reduced by approximately 50% in 2i TG mice compared with wild type mice. High fat feeding partially decreased insulin-stimulated glucose transport in wild type mice, while the high fat feeding resulted in a full blunting of insulin-stimulated glucose transport in the 2iTG mice. High fat feeding in 2i TG mice was accompanied by decreased expression of insulin signaling proteins in gastrocnemius muscle.
Conclusions: The lack of skeletal muscle AMPK 2 activity exacerbates the development of glucose intolerance and insulin resistance caused by high-fat feeding, and supports the thesis that AMPK 2 is an important target for the prevention/amelioration of skeletal muscle insulin resistance through lifestyle (exercise) and pharmacologic (e.g. metformin) treatments.
Correspondence:
laurie.goodyear{at}joslin.harvard.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2008 by the American Diabetes Association.
|
|
| |
|